Liquidia 과거 수익 실적
과거 기준 확인 0/6
Liquidia's earnings have been declining at an average annual rate of -13.2%, while the Pharmaceuticals industry saw earnings declining at 0.2% annually. Revenues have been growing at an average rate of 27.5% per year.
주요 정보
-13.2%
수익 성장률
22.4%
EPS 성장률
Pharmaceuticals 산업 성장 | 6.0% |
매출 성장률 | 27.5% |
자기자본 수익률 | -178.7% |
순이익 | -755.5% |
최근 수익 업데이트 | 30 Jun 2024 |
최근 과거 실적 업데이트
Recent updates
Is Liquidia (NASDAQ:LQDA) A Risky Investment?
Jul 18Broker Revenue Forecasts For Liquidia Corporation (NASDAQ:LQDA) Are Surging Higher
Jan 19Liquidia Corporation's (NASDAQ:LQDA) P/S Still Appears To Be Reasonable
Dec 20Is Liquidia (NASDAQ:LQDA) Using Debt In A Risky Way?
Aug 17Need To Know: Analysts Are Much More Bullish On Liquidia Corporation (NASDAQ:LQDA) Revenues
Mar 18Is Liquidia (NASDAQ:LQDA) Using Too Much Debt?
Feb 06Liquidia (NASDAQ:LQDA) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Oct 25Liquidia: United Manages A Temporary Win
Sep 12수익 및 비용 분석
Liquidia 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
---|---|---|---|---|
30 Jun 24 | 15 | -112 | 69 | 39 |
31 Mar 24 | 16 | -108 | 58 | 47 |
31 Dec 23 | 17 | -79 | 45 | 43 |
30 Sep 23 | 18 | -58 | 34 | 35 |
30 Jun 23 | 18 | -51 | 31 | 32 |
31 Mar 23 | 17 | -37 | 28 | 19 |
31 Dec 22 | 16 | -41 | 33 | 19 |
30 Sep 22 | 14 | -46 | 35 | 19 |
30 Jun 22 | 14 | -44 | 34 | 19 |
31 Mar 22 | 13 | -41 | 31 | 18 |
31 Dec 21 | 13 | -35 | 24 | 20 |
30 Sep 21 | 10 | -39 | 22 | 20 |
30 Jun 21 | 7 | -47 | 23 | 24 |
31 Mar 21 | 4 | -54 | 24 | 27 |
31 Dec 20 | 1 | -60 | 23 | 32 |
30 Sep 20 | 0 | -58 | 22 | 35 |
30 Jun 20 | 0 | -57 | 17 | 38 |
31 Mar 20 | 8 | -49 | 14 | 41 |
31 Dec 19 | 8 | -48 | 14 | 40 |
30 Sep 19 | 9 | -43 | 10 | 41 |
30 Jun 19 | 9 | -39 | 10 | 37 |
31 Mar 19 | 2 | -39 | 10 | 32 |
31 Dec 18 | 3 | -53 | 9 | 29 |
30 Sep 18 | 4 | -35 | 9 | 27 |
30 Jun 18 | 6 | -45 | 9 | 26 |
31 Mar 18 | 7 | -47 | 10 | 26 |
31 Dec 17 | 7 | -29 | 10 | 25 |
31 Dec 16 | 13 | -16 | 5 | 23 |
양질의 수익: LQDA is currently unprofitable.
이익 마진 증가: LQDA is currently unprofitable.
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: LQDA is unprofitable, and losses have increased over the past 5 years at a rate of 13.2% per year.
성장 가속화: Unable to compare LQDA's earnings growth over the past year to its 5-year average as it is currently unprofitable
수익 대 산업: LQDA is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (12.4%).
자기자본 수익률
높은 ROE: LQDA has a negative Return on Equity (-178.74%), as it is currently unprofitable.